Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

NCT06648785 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

OTHER

Sponsor class

Conditions

GI Cancers

Interventions

DRUG: oxaliplatin
DRUG: Fluoropyrimidine

Sponsor

University of Vermont Medical Center